Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Enalapril

An ACE inhibitor for high blood pressure and heart failure, patented in 1978 and in use since the mid-1980s: it was created to improve on captopril, the first medicine of its class. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?The active molecule is actually enalaprilat, which is poorly absorbed by mouth: by turning it into an ethyl ester, researchers obtained a prodrug that the body converts back into the active form.

EnalaprilGo to the active ingredient →
EnalaprilActive ingredientEnalaprilCat. No. P-E041-001CAS 75847-73-3
Enalaprilat-d5Isotopically labelledEnalaprilat-d5Cat. No. P-E041-020CAS 349554-00-3

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.